内容へ

鎌状赤血球症

血管閉塞性クリーゼおよび急性胸部症候群の治療管理

疼痛管理

What is the best pharmacologic treatment for sickle cell disease pain crises? (新しいタブで開く)

Baker M, Hafner JW.

出典‎: Ann Emerg Med 2012;59(6):515-6.

インデックス‎: PubMed 22221839

DOI‎: 10.1016/j.annemergmed.2011.11.026

https://www.ncbi.nlm.nih.gov/pubmed/22221839 (新しいタブで開く)

Update on pain management in sickle cell disease. (新しいタブで開く)

Ballas SK.

出典‎: Hemoglobin 2011;35(5-6):520-9.

インデックス‎: PubMed 21910604

DOI‎: 10.3109/03630269.2011.610478

https://www.ncbi.nlm.nih.gov/pubmed/21910604 (新しいタブで開く)

Reduction of painful vaso-occlusive crisis of sickle cell anaemia by tinzaparin in a double-blind randomized trial. (新しいタブで開く)

Qari MH, Aljaouni SK, Alardawi MS, Fatani H, Alsayes FM, Zografos P, Alsaigh M, Alalfi A, Alamin M, Gadi A, Mousa SA.

出典‎: Thromb Haemost 2007;98(2):392-6.

インデックス‎: PubMed 17721622

https://www.ncbi.nlm.nih.gov/pubmed/17721622 (新しいタブで開く)

補液療法(体液管理)

Fluid replacement therapy for acute episodes of pain in people with sickle cell disease. (新しいタブで開く)

Okomo U, Meremikwu MM.

出典‎: Cochrane Database Syst Rev 2012;(6):CD005406.

インデックス‎: PubMed 22696351

DOI‎: 10.1002/14651858.CD005406.pub3

https://www.ncbi.nlm.nih.gov/pubmed/22696351 (新しいタブで開く)

酸素投与

Guidelines for the management of the acute painful crisis in sickle cell disease. (新しいタブで開く)

Rees DC, Olujohungbe AD, Parker NE, Stephens AD, Telfer P, Wright J; British Committee for Standards in Haematology General Haematology Task Force by the Sickle Cell Working Party.

出典‎: Br J Haematol 2003;120(5):744-52.

インデックス‎: PubMed 12614204

https://www.ncbi.nlm.nih.gov/pubmed/12614204 (新しいタブで開く)

Hyperbaric oxygen therapy for vaso-occlusive crises in nine patients with sickle-cell disease. (新しいタブで開く)

Stirnemann J, Letellier E, Aras N, Borne M, Brinquin L, Fain O.

出典‎: Diving Hyperb Med 2012;42(2):82-4.

インデックス‎: PubMed 22828815

https://www.ncbi.nlm.nih.gov/pubmed/22828815 (新しいタブで開く)

抗菌薬・呼吸療法

Safety of purified poloxamer 188 in sickle cell disease: phase I study of a non-ionic surfactant in the management of acute chest syndrome. (新しいタブで開く)

Ballas SK, Files B, Luchtman-Jones L, Benjamin L, Swerdlow P, Hilliard L, Coates T, Abboud M, Wojtowicz-Praga S, Grindel JM.

出典‎: Hemoglobin 2004;28(2):85-102.

インデックス‎: PubMed 15182051

https://www.ncbi.nlm.nih.gov/pubmed/15182051 (新しいタブで開く)

Incentive spirometry to prevent acute pulmonary complications in sickle cell diseases. (新しいタブで開く)

Bellet PS, Kalinyak KA, Shukla R, Gelfand MJ, Rucknagel DL.

出典‎: N Engl J Med 1995;333(11):699-703.

インデックス‎: PubMed 7637747

DOI‎: 10.1056/NEJM199509143331104

https://www.ncbi.nlm.nih.gov/pubmed/7637747 (新しいタブで開く)

Continuous inhaled nitric oxide therapy in a case of sickle cell disease with multiorgan involvement. (新しいタブで開く)

Chang WL, Corate LM, Sinclair JM, van der Heyde HC.

出典‎: J Investig Med 2008;56(8):1023-7.

インデックス‎: PubMed 19050460

DOI‎: 10.2310/JIM.0b013e31818cb612

https://www.ncbi.nlm.nih.gov/pubmed/19050460 (新しいタブで開く)

Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. (新しいタブで開く)

Vichinsky EP, Neumayr LD, Earles AN, Williams R, Lennette ET, Dean D, Nickerson B, Orringer E, McKie V, Bellevue R, Daeschner C, Manci EA.

出典‎: N Engl J Med 2000;342(25):1855-65.

インデックス‎: PubMed 10861320

DOI‎: 10.1056/NEJM200006223422502

https://www.ncbi.nlm.nih.gov/pubmed/10861320 (新しいタブで開く)